We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.
ARTICLE · 30 JANUARY 2017
FDA Issues Draft Guidance On Biosimilar Interchangeability

Ropes & Gray LLP
Contributor

Ropes & Gray LLP
Ropes & Gray is one of the world’s most respected law firms, with offices in key business and...
View firm profileOn January 17, 2017, the Food and Drug Administration (FDA) issued draft guidance on "Considerations in Demonstrating Interchangeability With a Reference Product."
United StatesFood, Drugs, Healthcare, Life Sciences






